6 March 2023

Convergence of the company’s main banking partners on the principles of an agreement on an additional financing and the amendment of the june 2022 financing documentation

28 February 2023

ORPEA publication: ETHICS WITH YOU AND FOR YOU

23 February 2023

Extension of the conciliation procedure

14 February 2023

Signature of the lock-up agreement relating to the financial restructuring plan

13 February 2023

Q4 2022 revenue growth of +8,9%, at €4,681 m

Q4 2022 revenue growth of +8,9%, at €4,681 m
9 February 2023

Downwards thresholds crossing by CPPIB

1 February 2023

Agreement in principle on the financial restructuring plan with the CDC and a representative group of unsecured financial creditors

30 January 2023

Resumption of discussions between the Company, a group of French third-party investors led by the Caisse des Dépôts et Consignations and a group of unsecured financial creditors

19 January 2023

End of discussions between a consortium of french third-party investors led by the Caisse des Dépôts et Consignations and a group of unsecured financial creditors